Active substanceSimethiconeSimethicone Similar drugsTo uncover Antiflat Lannacher suspension inwards VALEANT, LLC Russia Antiflat Lannacher pills inwards VALEANT, LLC Russia Bobotik® drops inwards Medan Pharma, Joint Stock Company Poland Disflatil drops inwards Valant Pharmaceuticals Switzerland GmbH Switzerland Sub® simplex suspension inwards Pfizer Inc. USA Espumizan® capsules inwards Berlin-Chemie / Menarini Pharma, GmbH Germany Espumizan® 40 emulsion inwards BERLIN-PHARMA, CJSC Russia Espumizan® L emulsion inwards Berlin-Chemie, AG Germany Espumizan® baby drops inwards Berlin-Chemie, AG Germany Espumizan® extra granules inwards Berlin-Chemie, AG Germany Dosage form: & nbspcapsules Composition: One capsule contains: Active substance: simethicone 40.0 mg Excipients : gelatin, glycerol 85%, methyl parahydroxybenzoate, dye quinoline yellow (E 104), dye sunset yellow sunset (E 110). Description: Round or nearly round, soft, yellow gelatin capsules with seam and smooth surface. Contents of the capsule, colorless, viscous, translucent liquid. Pharmacotherapeutic group:carminative ATX: & nbspA.03.A.X Other drugs used in bowel disorders Pharmacodynamics: Carminative.Reducing the surface tension at the interface, complicates the formation and promotes the destruction of gas bubbles in the nutrient suspension and mucus of the gastrointestinal tract (GIT). The gases released in this way can be absorbed by the walls of the intestine or removed through peristalsis. When sonogram and radiography prevents interference and overlapping images; promotes better irrigation of the mucous membrane of the colon with a constipid drug, preventing the rupture of the contrast film. Pharmacokinetics: Due to physiological and chemical inertness is not absorbed in the body, after passing through the gastrointestinal tract is withdrawn in an unchanged form. Indications: increased gas formation and accumulation of gases in the digestive tract (flatulence, Remmeld's syndrome, aerophagia, formation of gases in the postoperative period); preparation for diagnostic procedures of the abdominal and pelvic organs (radiography, sonography). Dosing and Administration: Inside, adults and children over 6 years of 2 capsules 3-4 times a day, you can with a small amount of fluid, after each meal and at bedtime. Preparation for research: 2 capsules 3 times a day the day before the study, 2 capsules on the morning of the day of the study. Side effects: Adverse effects during admission of Espumizan® is not observedElk. Possible the development of allergic reactions to the components of the drug. Interaction: Clinically significant interaction of Espumizan® with other medications has not been established. Form release / dosage: Capsules 40 mg. For 25 capsules in a PVC blister / aluminum foil. For 1, 2 or 4 blisters in a cardboard box together with instructions for use. Packaging: Capsules 40 mg. For 25 capsules in a PVC blister / aluminum foil. For 1, 2 or 4 blisters in a cardboard box together with instructions for use. Storage conditions: Store at a temperature not exceeding 30 ° C, out of the reach of children Shelf life: 3 years Do not use after the expiry date of the drug! Terms of leave from pharmacies:Without recipe Registration number:П N013460 / 01 Date of registration:13.04.2012 The owner of the registration certificate:Berlin-Chemie / Menarini Pharma, GmbH Berlin-Chemie / Menarini Pharma, GmbH Germany Manufacturer: & nbspBERLIN-CHEMIE, AG Germany Information update date: & nbsp05.08.2015 Illustrated instructions × Illustrated instructions Instructions